AMCR: Bearish Signals Emerge - Time for Puts?

Amcor is a global leader in developing and producing consumer packaging and dispensing solutions. The company operates through two reportable segments: 'Global Flexible Packaging Solutions', which supplies polymer resin, aluminum, and fiber-based flexible packaging, and 'Global Rigid Packaging Solutions', which manufactures rigid packaging containers, closures, dispensing and pharma devices. Amcor serves customers in the nutrition, health, beauty, and wellness categories across Europe, North America, Latin America, the Middle East, Africa, and the Asia Pacific regions. The company's business strategy focuses on customers, sustainability and innovation, and portfolio management. Amcor differentiates itself by offering a wide range of multi-format packaging solutions, leveraging its technical know-how, business experience, and expertise across various packaging materials, including paper, aluminum, polymer resins, and recycled and bio-based materials. Amcor also emphasizes sustainability by driving circularity and decarbonization through product innovation and waste management infrastructure.

No relevant news was found for this stock today.

AMCR's technical indicators suggest a bearish outlook for the next 1-3 months. The stock price has experienced a significant downtrend over the past 90 days, falling from approximately $9.19 on July 1st to $7.865 as of November 4th. The price is currently below its 50-day SMA (8.1853) and estimated 200-day SMA (9.10515), confirming the downtrend. Momentum indicators also reflect weakness; the MACD is negative (-0.06778892936401526) and below its signal line (-0.051651411401542245), and the RSI is low at 38.86997140879244, indicating oversold conditions but also sustained selling pressure. The Stochastic Oscillator shows the %K line (20.38879888914603) below the %D line (25.424695425239925), indicating further bearish momentum. Recent price action confirms this bearish sentiment, with the price failing to sustain any significant rallies. The Bollinger Bands show the price near the lower band (7.761754793351528), suggesting potential for continued downside. Given these factors, a further decline is probable in the short to medium term.

Amcor's MD&A reveals a mixed financial performance. `Net sales` for the three months ended March 31, 2025, decreased by 2% to $3,333 million compared to $3,411 million in the prior year. The `Gross profit` margin also declined slightly from 20.3% to 19.6% over the same period, driven by negative currency impacts and disposals, partially offset by improved operating cost performance. For the nine-month period, `Net cash provided by operating activities` decreased by $102 million to $276 million, driven by higher working capital outflows, mainly impacted by higher inventories. Amcor completed the Berry Global Group merger on April 30, 2025, issuing approximately 846 million ordinary shares and paying $2.2 billion in Berry indebtedness. Management notes 'market dynamics remain challenging with softer consumer demand and customer order volatility in certain markets, and higher costs in certain areas, including labor costs'. While the company has benefited from overall sales volume growth of 1% through the first nine months of fiscal year 2025, they acknowledge that 'there is no assurance that we will meet our performance expectations' given 'geopolitical tensions, including disruptions related to tariffs and other factors' that 'may negatively impact our financial results'.

Amcor's fiscal 2025 Q4 earnings call reveals a mixed outlook following the acquisition of Berry Global. While the acquisition drove significant increases in net sales, EBITDA, and EBIT, the performance of legacy businesses 'fell short of our expectations' due to sequentially weaker volumes, particularly in North America. Management highlighted 'operating challenges at a few high-volume sites' within the North American beverage business, leading to elevated costs, which they are actively addressing by creating a dedicated beverage business unit. Despite these challenges, Amcor reaffirmed its commitment to delivering $650 million in total synergies through fiscal '28, including $260 million in fiscal '26, largely driven by self-help actions. The company expects strong adjusted EPS growth of 12% to 17% in fiscal '26 and anticipates free cash flow to double to $1.8 billion to $1.9 billion. They are also exploring alternatives for businesses with combined annual sales of approximately $2.5 billion that are 'less aligned with our go-forward core portfolio,' including the North American beverage business. Overall, the company is confident in achieving its financial targets, driven by synergy realization and portfolio optimization, but faces near-term headwinds from weaker volumes and operational challenges.

AMCR's financial performance presents a mixed picture. Revenue has shown volatility, starting at $3,443,000,000 in Q1 2024 and reaching $5,082,000,000 in Q4 2025, indicating potential growth but also inconsistency. The gross profit ratio has fluctuated, with a high of 0.213 in Q4 2024 and a low of 0.176 in the most recent quarter, suggesting margin pressure. Operating cash flow is highly variable, with a significant outflow of -$269,000,000 in Q1 2024 but a strong positive flow of $1,114,000,000 in Q4 2025. Total debt has increased substantially from $7,558,000,000 in Q1 2024 to $15,008,000,000 in Q4 2025, signaling increased leverage and potential risk. The net income decreased from $152,000,000 in Q1 2024 to a net loss of -$39,000,000 in Q4 2025. The increased debt and fluctuating profitability, coupled with inconsistent cash flow, raise concerns about the company's short-term financial health despite the revenue peaks.

The company demonstrates a moderately bullish profile, characterized by solid revenue growth and improving profitability. Revenue has consistently increased, indicating strong market demand. The gross margin exhibits stability, suggesting efficient cost management. Return on Equity (ROE) has shown positive movement, signaling enhanced profitability and efficient use of shareholder equity. The Price-to-Earnings (P/E) ratio, while elevated, might be justifiable given the growth trajectory and positive ROE trend. The Debt-to-Equity ratio shows a slight increase, which warrants monitoring, but is counterbalanced by a healthy Current Ratio, implying sufficient liquidity to meet short-term obligations. Overall, the company presents a favorable picture with growth and profitability, though the leverage should be watched closely. The combination of growth and profitability suggests potential for continued positive performance over the next 12 months.